Ask AI

Charting a New Course in Severe Hypertriglyceridemia Care: Optimizing Diagnosis, Therapeutic Strategies, and Pancreatitis Prevention in sHTG and FCS

Better understand the pathophysiology of severe hypertriglyceridemia (sHTG) and familial chylomicronemia (FCS) and gain strategies for integrating emerging sHTG and FCS therapies in patient-centered, evidence-based care plans, through an expert-written ClinicalThought, downloadable slides, and an on-demand webcast.

Share

Program Content

Events

Activities

Severe Hypertriglyceridemia and FCS
Charting a New Course in Severe Hypertriglyceridemia Care: Optimizing Diagnosis, Therapeutic Strategies, and Pancreatitis Prevention in sHTG and FCS
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.